Copyright Reports & Markets. All rights reserved.

Global Cell and Gene Therapy Manufacturing Services Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Cell and Gene Therapy Manufacturing Services Market Status and Forecast (2017-2028)
      • 1.3.2 Global Cell and Gene Therapy Manufacturing Services Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Cell and Gene Therapy Manufacturing Services Supply by Company

    • 2.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume by Company
    • 2.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Company
    • 2.3 Global Cell and Gene Therapy Manufacturing Services Price by Company
    • 2.4 Cell and Gene Therapy Manufacturing Services Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Cell and Gene Therapy Manufacturing Services Market Status by Type

    • 3.1 Cell and Gene Therapy Manufacturing Services Type Introduction
      • 2.2.1 Type I
      • 2.2.2 Type II
    • 3.2 Global Cell and Gene Therapy Manufacturing Services Market by Type
      • 3.2.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume by Type (2017-2022)
      • 3.2.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Type (2017-2022)
      • 3.2.3 Global Cell and Gene Therapy Manufacturing Services Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Cell and Gene Therapy Manufacturing Services Market Status by Application

    • 4.1 Cell and Gene Therapy Manufacturing Services Segment by Application
      • 4.1.1 Oncology Diseases
      • 4.1.2 Cardiovascular Diseases
      • 4.1.3 Orthopedic Diseases
      • 4.1.4 Ophthalmology Diseases
      • 4.1.5 Infectious Diseases
      • 4.1.6 Others
    • 4.2 Global Cell and Gene Therapy Manufacturing Services Market by Application
      • 4.2.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume by Application (2017-2022)
      • 4.2.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Application (2017-2022)
      • 4.2.3 Global Cell and Gene Therapy Manufacturing Services Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Cell and Gene Therapy Manufacturing Services Market Status by Region

    • 5.1 Global Cell and Gene Therapy Manufacturing Services Market by Region
      • 5.1.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume by Region
      • 5.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Value by Region
    • 5.2 North America Cell and Gene Therapy Manufacturing Services Market Status
    • 5.3 Europe Cell and Gene Therapy Manufacturing Services Market Status
    • 5.4 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Status
    • 5.5 Central & South America Cell and Gene Therapy Manufacturing Services Market Status
    • 5.6 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Status

    6 North America Cell and Gene Therapy Manufacturing Services Market Status

    • 6.1 North America Cell and Gene Therapy Manufacturing Services Market by Country
      • 6.1.1 North America Cell and Gene Therapy Manufacturing Services Sales Volume by Country (2017-2022)
      • 6.1.2 North America Cell and Gene Therapy Manufacturing Services Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Cell and Gene Therapy Manufacturing Services Market Status

    • 7.1 Europe Cell and Gene Therapy Manufacturing Services Market by Country
      • 7.1.1 Europe Cell and Gene Therapy Manufacturing Services Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Cell and Gene Therapy Manufacturing Services Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Status

    • 8.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Market by Country
      • 8.1.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Cell and Gene Therapy Manufacturing Services Market Status

    • 9.1 Central & South America Cell and Gene Therapy Manufacturing Services Market by Country
      • 9.1.1 Central & South America Cell and Gene Therapy Manufacturing Services Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Cell and Gene Therapy Manufacturing Services Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Status

    • 10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market by Country
      • 10.1.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Cell and Gene Therapy Manufacturing Services Manufacturing Cost Analysis
    • 11.5 Cell and Gene Therapy Manufacturing Services Sales Channel and Distributors Analysis
      • 11.5.1 Cell and Gene Therapy Manufacturing Services Sales Channel
      • 11.5.2 Cell and Gene Therapy Manufacturing Services Distributors
    • 11.6 Cell and Gene Therapy Manufacturing Services Downstream Major Buyers

    12 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Type and by Application

    • 12.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Cell and Gene Therapy Manufacturing Services Forecast by Type
      • 12.2.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume Forecast by Type
      • 12.2.2 Global Cell and Gene Therapy Manufacturing Services Sales Value Forecast by Type
      • 12.2.3 Global Cell and Gene Therapy Manufacturing Services Price Forecast by Type
    • 12.3 Global Cell and Gene Therapy Manufacturing Services Forecast by Application
      • 12.3.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume Forecast by Application
      • 12.3.2 Global Cell and Gene Therapy Manufacturing Services Sales Value Forecast by Application
      • 12.3.3 Global Cell and Gene Therapy Manufacturing Services Price Forecast by Application

    13 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Region/Country

    • 13.1 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Region (2023-2028)
      • 13.1.1 Global Cell and Gene Therapy Manufacturing Services Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 WuXi AppTec
      • 14.1.1 Company Information
      • 14.1.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.1.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Vibalogics
      • 14.2.1 Company Information
      • 14.2.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.2.3 Vibalogics Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Thermo Fisher Scientific
      • 14.3.1 Company Information
      • 14.3.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.3.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 The Discovery Labs LLC
      • 14.4.1 Company Information
      • 14.4.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.4.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Takara Bio Inc
      • 14.5.1 Company Information
      • 14.5.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.5.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 RoslinCT
      • 14.6.1 Company Information
      • 14.6.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.6.3 RoslinCT Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Resilience
      • 14.7.1 Company Information
      • 14.7.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.7.3 Resilience Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Porton Biopharma Limited
      • 14.8.1 Company Information
      • 14.8.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.8.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Oxford Biomedica Plc
      • 14.9.1 Company Information
      • 14.9.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.9.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Nikon Corporation
      • 14.10.1 Company Information
      • 14.10.2 Cell and Gene Therapy Manufacturing Services Product Introduction
      • 14.10.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Merck KGaA
    • 14.12 Lonza
    • 14.13 JRS PHARMA
    • 14.14 FUJIFILM Holdings Corporation
    • 14.15 FinVector
    • 14.16 F. Hoffmann-La Roche
    • 14.17 ElevateBio
    • 14.18 Commercializing Living Therapies
    • 14.19 Charles River Laboratories
    • 14.20 Cell and Gene Therapy Catapult
    • 14.21 Catalent
    • 14.22 BioCentriq
    • 14.23 Anemocyte Srl
    • 14.24 Andelyn Biosciences
    • 14.25 ABL

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Cell and Gene Therapy Manufacturing Services market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Cell and Gene Therapy Manufacturing Services industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Cell and Gene Therapy Manufacturing Services market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Cell and Gene Therapy Manufacturing Services Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy Manufacturing Services market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Cell and Gene Therapy Manufacturing Services Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Cell and Gene Therapy Manufacturing Services industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Type I
      Type II

      Segmented by Application
      Oncology Diseases
      Cardiovascular Diseases
      Orthopedic Diseases
      Ophthalmology Diseases
      Infectious Diseases
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Thermo Fisher Scientific
      The Discovery Labs LLC
      Takara Bio Inc
      RoslinCT
      Resilience
      Porton Biopharma Limited
      Oxford Biomedica Plc
      Nikon Corporation
      Merck KGaA
      Lonza
      JRS PHARMA
      FUJIFILM Holdings Corporation
      FinVector
      F. Hoffmann-La Roche
      ElevateBio
      Commercializing Living Therapies
      Charles River Laboratories
      Cell and Gene Therapy Catapult
      Catalent
      BioCentriq
      Anemocyte Srl
      Andelyn Biosciences
      ABL
      Buy now